TNGX
Tango Therapeutics, Inc.
Company overview
- Market capitalization
- $4.10B
- Employees
- 137
- Latest publication
- 2026-09-29
About Tango Therapeutics, Inc.
Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase (STK) 11 loss-of-function mutations to treat lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 53,811,000USD | 3,181,000USD | 5,392,000USD | 4,117,000USD | 11,607,000USD |
| Research Development | 37,199,000USD | 33,070,999USD | 33,281,000USD | 30,815,000USD | 32,182,000USD | 36,442,000USD | 33,937,000USD | 33,263,000USD |
| Selling General Administrative | 22,586,000USD | 15,235,000USD | 9,763,000USD | 8,924,000USD | 11,341,000USD | 11,480,000USD | 11,090,000USD | 11,222,000USD |
| General And Administrative Expenses | 22,586,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 59,785,000USD | 48,306,000USD | 41,385,000USD | 39,739,000USD | 43,523,000USD | 47,922,000USD | 45,027,000USD | 44,485,000USD |
| Operating Income | -59,785,000USD | -48,769,000USD | -41,864,000USD | 14,072,000USD | -40,967,000USD | -42,530,000USD | -40,910,000USD | -32,878,000USD |
| Total Other Income Expense Net | 4,445,000USD | 3,256,000USD | 3,060,000USD | 1,802,000USD | 2,149,000USD | 2,688,000USD | 3,289,000USD | 3,765,000USD |
| Net Interest Income | 3,723,000USD | 2,177,000USD | 1,680,000USD | 1,097,000USD | 1,239,000USD | 1,614,000USD | 1,813,000USD | 1,809,000USD |
| Income Before Tax | -55,340,000USD | -45,513,000USD | -38,804,000USD | 15,874,000USD | -38,818,000USD | -39,842,000USD | -37,621,000USD | -29,113,000USD |
| Income Tax Expense | 1,000USD | 1,000USD | -55,000USD | -10,000USD | 35,000USD | 34,000USD | 49,000USD | 54,000USD |
| Net Income | -55,341,000USD | -45,514,000USD | -38,749,000USD | 15,884,000USD | -38,853,000USD | -39,876,000USD | -37,670,000USD | -29,167,000USD |
| Cost Of Revenue | — | 463,000USD | 479,000USD | 555,000USD | 625,000USD | — | 620,000USD | — |
| Gross Profit | — | -463,000USD | -479,000USD | 53,811,000USD | 2,556,000USD | 5,392,000USD | 4,117,000USD | 11,607,000USD |
| Interest Income | — | 2,177,000USD | 1,680,000USD | 1,097,000USD | 1,239,000USD | 1,614,000USD | 1,813,000USD | 1,809,000USD |
| Tax Provision | — | 1,000USD | -55,000USD | -10,000USD | 35,000USD | 34,000USD | 49,000USD | 54,000USD |
| Net Income From Continuing Ops | — | -45,514,000USD | -38,749,000USD | 15,884,000USD | -38,853,000USD | -39,876,000USD | -37,670,000USD | -29,167,000USD |
| Ebit | — | -45,513,000USD | -38,804,000USD | 15,874,000USD | -38,818,000USD | -39,842,000USD | -37,621,000USD | -29,113,000USD |
| Ebitda | — | -45,050,000USD | -38,325,000USD | 16,429,000USD | -38,193,000USD | -39,220,000USD | -37,001,000USD | -28,491,000USD |
| Depreciation And Amortization | — | 463,000USD | 479,000USD | 555,000USD | 625,000USD | 622,000USD | 620,000USD | 622,000USD |
| Reconciled Depreciation | — | 463,000USD | 479,000USD | 555,000USD | 625,000USD | 622,000USD | 620,000USD | 622,000USD |
| Unclassified Operating Expenses | — | — | -1,659,000USD | — | — | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|
| Total Revenue | 42,069,000USD | 36,527,000USD | 24,860,000USD | 37,042,000USD |
| Cost Of Revenue | 2,499,000USD | 115,198,000USD | 4,027,999USD | 1,966,000USD |
| Gross Profit | 42,069,000USD | 36,527,000USD | 24,860,000USD | 37,042,000USD |
| Research Development | 143,918,000USD | 115,198,000USD | 105,906,000USD | 77,636,000USD |
| Selling General Administrative | 43,746,000USD | 35,502,000USD | 30,025,000USD | 17,596,000USD |
| Total Operating Expenses | 187,664,000USD | 150,700,000USD | 135,931,000USD | 95,232,000USD |
| Operating Income | -145,595,000USD | -114,173,000USD | -111,071,000USD | -58,190,000USD |
| Interest Income | 7,890,000USD | 4,974,000USD | 1,456,000USD | 495,000USD |
| Net Interest Income | 7,890,000USD | 4,974,000USD | 1,456,000USD | 495,000USD |
| Income Before Tax | -130,094,000USD | -101,610,000USD | -108,122,000USD | -57,943,000USD |
| Income Tax Expense | 208,000USD | 134,000USD | 54,000USD | 292,000USD |
| Tax Provision | 208,000USD | 138,000USD | 54,000USD | 292,000USD |
| Net Income | -130,302,000USD | -101,744,000USD | -108,176,000USD | -58,235,000USD |
| Net Income From Continuing Ops | -130,302,000USD | -100,041,000USD | -108,176,000USD | -58,235,000USD |
| Ebit | -130,094,000USD | -101,610,000USD | -111,071,000USD | -58,190,000USD |
| Ebitda | -127,595,000USD | -99,195,000USD | -109,463,000USD | -57,293,000USD |
| Depreciation And Amortization | 2,499,000USD | 2,415,000USD | 1,608,000USD | 897,000USD |
| Reconciled Depreciation | 2,499,000USD | 2,368,000USD | 1,608,000USD | 897,000USD |
| Total Other Income Expense Net | 15,501,000USD | 12,563,000USD | 2,949,000USD | 247,000USD |
| Interest Expense | — | — | 2,949,000USD | 1,144,000USD |
| Non Operating Income Net Other | — | — | -1,447,000USD | -1,030,000USD |
| Net Income Applicable To Common Shares | — | — | -108,176,000USD | -58,235,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,073,880,000USD | 435,792,000USD | 398,690,000USD | 210,136,000USD | 237,890,000USD | 274,306,000USD | 316,492,000USD | 352,415,000USD |
| Cash And Equivalents | 345,558,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 1,013,990,000USD | 379,839,000USD | 343,138,000USD | 152,811,000USD | 180,785,000USD | 216,724,000USD | 257,917,000USD | 293,278,000USD |
| Short Term Investments | 668,432,000USD | 222,011,000USD | 230,859,000USD | 94,473,000USD | 141,513,000USD | 158,292,000USD | 188,387,000USD | 240,130,000USD |
| Total Current Assets | 1,031,671,000USD | 392,327,000USD | 353,756,000USD | 163,779,000USD | 190,100,000USD | 224,930,000USD | 266,343,000USD | 300,815,000USD |
| Other Current Assets | 17,681,000USD | 12,488,000USD | 10,618,000USD | 10,968,000USD | 9,315,000USD | 8,206,000USD | 8,426,000USD | 7,537,000USD |
| Other Non Current Assets | 312,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 49,348,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 20,299,000USD | 14,330,000USD | 21,679,000USD | 18,444,000USD | 40,025,000USD | 35,917,000USD | 38,170,000USD | 37,583,000USD |
| Total Stockholder Equity | 1,024,532,000USD | 391,506,000USD | 346,179,000USD | 160,031,000USD | 134,954,000USD | 166,756,000USD | 199,517,000USD | 229,170,000USD |
| Total Equity Including Noncontrolling Interest | 1,024,532,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 39,758,000USD | 41,033,000USD | 42,492,000USD | 43,928,000USD | 45,341,000USD | 47,236,000USD | 47,578,000USD | 49,020,000USD |
| Accounts Payable | 1,810,000USD | 2,430,000USD | 1,182,000USD | 2,229,000USD | 2,607,000USD | 3,239,000USD | 1,601,000USD | 4,112,000USD |
| Short Term Debt | 2,943,000USD | 2,832,000USD | 2,738,000USD | 3,102,000USD | 2,534,000USD | 2,824,000USD | 2,454,000USD | 2,863,000USD |
| Common Stock | 168,000USD | 144,000USD | 136,000USD | 112,000USD | 111,000USD | 108,000USD | 108,000USD | 107,000USD |
| Retained Earnings | -704,007,000USD | -648,666,000USD | -603,152,000USD | -564,403,000USD | -580,287,000USD | -541,434,000USD | -501,558,000USD | -463,888,000USD |
| Accumulated Other Comprehensive Income | -633,000USD | -115,000USD | 224,000USD | 120,999USD | 94,000USD | 194,000USD | 336,000USD | 750,000USD |
| Total Liab | — | 44,286,000USD | 52,511,000USD | 50,105,000USD | 102,936,000USD | 107,550,000USD | 116,975,000USD | 123,245,000USD |
| Other Current Liab | — | 9,068,000USD | 17,759,000USD | 13,113,000USD | 11,510,000USD | 10,374,000USD | 16,497,000USD | 15,006,000USD |
| Capital Stock | — | 144,000USD | 136,000USD | 112,000USD | 111,000USD | 108,000USD | 108,000USD | 107,000USD |
| Cash | — | 157,828,000USD | 112,279,000USD | 58,338,000USD | 39,272,000USD | 58,432,000USD | 69,530,000USD | 53,148,000USD |
| Net Debt | — | -125,040,000USD | -78,709,000USD | -23,575,000USD | -4,264,000USD | -21,486,000USD | -33,037,000USD | -15,522,000USD |
| Short Long Term Debt Total | — | 32,788,000USD | 33,570,000USD | 34,763,000USD | 35,008,000USD | 36,946,000USD | 36,493,000USD | 37,626,000USD |
| Property Plant Equipment Gross | — | 51,974,000USD | 53,030,000USD | 53,988,000USD | 54,951,000USD | 56,221,000USD | 55,941,000USD | 56,763,000USD |
| Common Stock Shares Outstanding | — | 143,576,292shares | 116,166,187shares | 110,966,345shares | 110,540,836shares | 110,301,256shares | 108,683,920shares | 108,507,000shares |
| Non Current Assets Total | — | 43,465,000USD | 44,934,000USD | 46,357,000USD | 47,790,000USD | 49,376,000USD | 50,149,000USD | 51,600,000USD |
| Non Current Liabilities Total | — | 29,956,000USD | 30,832,000USD | 31,661,000USD | 62,911,000USD | 71,633,000USD | 78,805,000USD | 85,662,000USD |
| Non Currrent Assets Other | — | 2,432,000USD | 2,442,000USD | 2,429,000USD | 2,449,000USD | 2,140,000USD | 2,571,000USD | 2,580,000USD |
| Net Working Capital | — | 377,997,000USD | 332,077,000USD | 145,335,000USD | 150,075,000USD | 189,013,000USD | 228,173,000USD | 263,232,000USD |
| Unclassified Non Current Liabilities | — | 29,956,000USD | 30,832,000USD | 31,661,000USD | 62,911,000USD | 71,633,000USD | 78,805,000USD | 85,662,000USD |
| Unclassified Equity | — | 1,039,999,000USD | 948,835,000USD | 724,089,001USD | 714,925,000USD | 707,780,000USD | 700,523,000USD | 692,094,000USD |
| Current Deferred Revenue | — | — | — | — | 23,374,000USD | 19,480,000USD | 17,618,000USD | 15,602,000USD |
| Other Assets | — | — | — | — | — | — | -12,450,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 398,690,000USD | 316,492,000USD | 402,567,000USD | 436,470,000USD | 500,155,000USD | 207,252,000USD | 55,764,000USD |
| Other Current Assets | 10,618,000USD | 8,426,000USD | 9,653,000USD | 7,139,000USD | 5,083,000USD | 1,312,000USD | 1,231,000USD |
| Total Liab | 52,511,000USD | 116,975,000USD | 149,459,000USD | 186,994,000USD | 155,408,000USD | 168,652,000USD | 47,859,000USD |
| Total Stockholder Equity | 346,179,000USD | 199,517,000USD | 253,108,000USD | 249,476,000USD | 344,747,000USD | 38,600,000USD | 7,905,000USD |
| Other Current Liab | 17,759,000USD | 16,497,000USD | 15,401,000USD | 17,495,000USD | 9,887,000USD | 6,140,000USD | 24,526,000USD |
| Common Stock | 136,000USD | 108,000USD | 102,000USD | 88,000USD | 88,000USD | 40,000USD | 13,000USD |
| Capital Stock | 136,000USD | 108,000USD | 102,000USD | 88,000USD | 88,000USD | 40,000USD | — |
| Retained Earnings | -603,152,000USD | -501,558,000USD | -371,256,000USD | -269,512,000USD | -161,336,000USD | -103,101,000USD | -51,129,000USD |
| Cash | 112,279,000USD | 69,530,000USD | 66,385,000USD | 59,968,000USD | 142,745,000USD | 28,381,000USD | 22,889,000USD |
| Cash And Short Term Investments | 343,138,000USD | 257,917,000USD | 336,885,000USD | 366,133,000USD | 485,255,000USD | 190,320,000USD | 40,425,000USD |
| Total Current Assets | 353,756,000USD | 266,343,000USD | 346,538,000USD | 375,272,000USD | 492,338,000USD | 193,632,000USD | 41,656,000USD |
| Total Current Liabilities | 21,679,000USD | 38,170,000USD | 45,938,000USD | 55,545,000USD | 40,690,000USD | 40,917,000USD | 25,851,000USD |
| Net Debt | -78,709,000USD | -33,037,000USD | -27,465,000USD | -18,837,000USD | -141,242,000USD | -20,497,000USD | -14,350,000USD |
| Short Term Debt | 2,738,000USD | 2,454,000USD | 2,082,000USD | 1,770,000USD | 1,503,000USD | 959,000USD | 655,000USD |
| Short Long Term Debt Total | 33,570,000USD | 36,493,000USD | 38,920,000USD | 41,131,000USD | 1,503,000USD | 7,884,000USD | 8,539,000USD |
| Short Term Investments | 230,859,000USD | 188,387,000USD | 270,500,000USD | 306,165,000USD | 342,510,000USD | 161,939,000USD | 17,536,000USD |
| Accounts Payable | 1,182,000USD | 1,601,000USD | 2,785,000USD | 4,453,000USD | 3,226,000USD | 1,841,000USD | 670,000USD |
| Property Plant Equipment Net | 42,492,000USD | 47,578,000USD | 53,416,000USD | 57,770,000USD | 6,086,000USD | 11,303,000USD | 11,829,000USD |
| Property Plant Equipment Gross | 53,030,000USD | 55,941,000USD | 59,405,000USD | 57,770,000USD | 6,086,000USD | 12,987,000USD | — |
| Accumulated Other Comprehensive Income | 224,000USD | 336,000USD | 186,000USD | -3,705,000USD | -765,000USD | 17,000USD | 10,000USD |
| Common Stock Shares Outstanding | 116,166,187shares | 109,226,731shares | 94,572,448shares | 87,820,037shares | 62,108,032shares | 87,474,258shares | 87,474,258shares |
| Non Current Assets Total | 44,934,000USD | 50,149,000USD | 56,029,000USD | 61,198,000USD | 7,817,000USD | 13,620,000USD | 14,108,000USD |
| Non Current Liabilities Total | 30,832,000USD | 78,805,000USD | 103,521,000USD | 131,449,000USD | 114,718,000USD | 127,735,000USD | 22,008,000USD |
| Non Currrent Assets Other | 2,442,000USD | 2,571,000USD | 2,613,000USD | 3,428,000USD | 1,731,000USD | 2,317,000USD | 2,279,000USD |
| Net Working Capital | 332,077,000USD | 228,173,000USD | 300,600,000USD | 319,727,000USD | 451,648,000USD | 152,715,000USD | — |
| Unclassified Non Current Liabilities | 30,832,000USD | 78,805,000USD | 103,521,000USD | — | -114,718,000USD | 6,920,000USD | 7,884,000USD |
| Unclassified Equity | 948,835,000USD | 700,523,000USD | 623,974,000USD | 522,517,000USD | 506,672,000USD | 141,604,000USD | 59,011,000USD |
| Current Deferred Revenue | — | 17,618,000USD | 25,670,000USD | 31,792,000USD | 26,022,000USD | 31,977,000USD | — |
| Net Receivables | — | — | 0USD | 2,000,000USD | 2,000,000USD | 2,000,000USD | — |
| Inventory | — | — | — | 567,000USD | 567,000USD | — | — |
| Non Current Liabilities Other | — | — | — | 131,449,000USD | 114,718,000USD | 5,000USD | — |
| Net Tangible Assets | — | — | — | 249,476,000USD | 344,747,000USD | -97,944,000USD | -47,795,000USD |
| Other Liab | — | — | — | — | 114,718,000USD | 120,810,000USD | 14,124,000USD |
| Other Assets | — | — | — | — | 1,731,000USD | 166,815,235USD | 2,279,000USD |
| Unclassified Non Current Assets | — | — | — | — | -1,731,000USD | -166,815,235USD | -2,279,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 888,000USD |
| Stock Based Compensation | 27,689,000USD |
| Other Non Cash Items | -3,000USD |
| Change In Working Capital | -7,500,000USD |
| Operating Cash Flow | -83,226,000USD |
| Capital Expenditures | -22,000USD |
| Net Investments | -436,360,000USD |
| Unclassified Investing Cash Flow | 44,000USD |
| Investing Cash Flow | -436,338,000USD |
| Common Stock Issuance | 38,229,000USD |
| Unclassified Financing Cash Flow | 714,186,000USD |
| Financing Cash Flow | 752,415,000USD |
| Change In Cash | 232,851,000USD |
| End Cash Flow | 347,697,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -45,514,000USD | -38,749,000USD | 15,884,000USD | -38,853,000USD | -39,876,000USD | -37,670,000USD | -29,167,000USD | -25,551,000USD |
| Depreciation | 463,000USD | 479,000USD | 555,000USD | 625,000USD | 622,000USD | 620,000USD | 622,000USD | 632,000USD |
| Stock Based Compensation | 10,797,000USD | 5,980,000USD | 6,625,000USD | 6,570,000USD | 7,255,000USD | 7,462,000USD | 7,178,000USD | 7,538,000USD |
| Other Non Cash Items | -63,000USD | 171,000USD | 412,000USD | 295,000USD | 318,000USD | 88,000USD | -245,000USD | -236,000USD |
| Change In Working Capital | -10,043,000USD | 2,401,000USD | -54,428,000USD | -5,156,000USD | -10,016,000USD | -7,147,000USD | -11,778,000USD | -5,990,000USD |
| Total Cash From Operating Activities | -44,360,000USD | -29,718,000USD | -30,952,000USD | -36,519,000USD | -41,697,000USD | -36,647,000USD | -33,390,000USD | -23,607,000USD |
| Capital Expenditures | -2,000USD | -222,000USD | -151,000USD | -624,000USD | -51,000USD | -124,000USD | -115,000USD | -320,000USD |
| Free Cash Flow | -44,358,000USD | -29,940,000USD | -31,103,000USD | -37,143,000USD | -41,748,000USD | -36,771,000USD | -33,505,000USD | -23,927,000USD |
| Investments | 9,633,000USD | -135,495,000USD | 47,477,000USD | 16,778,000USD | 30,597,000USD | 52,060,000USD | 32,570,000USD | 12,699,000USD |
| Total Cashflows From Investing Activities | 9,635,000USD | -135,717,000USD | 47,477,000USD | 16,778,000USD | 30,597,000USD | 52,060,000USD | 32,570,000USD | 12,699,000USD |
| Total Cash From Financing Activities | 79,846,000USD | 219,376,000USD | 2,541,000USD | 581,000USD | 2,000USD | 969,000USD | 2,402,000USD | 1,311,000USD |
| Issuance Of Capital Stock | 62,778,000USD | 212,400,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Change In Cash | 45,121,000USD | 53,941,000USD | 19,066,000USD | -19,160,000USD | -11,098,000USD | 16,382,000USD | 1,582,000USD | -9,597,000USD |
| Begin Period Cash Flow | 114,846,000USD | 60,905,000USD | 39,700,000USD | 60,999,000USD | 72,097,000USD | 55,715,000USD | 54,133,000USD | 63,730,000USD |
| End Period Cash Flow | 159,967,000USD | 114,846,000USD | 58,766,000USD | 41,839,000USD | 60,999,000USD | 72,097,000USD | 55,715,000USD | 54,133,000USD |
| Other Cashflows From Financing Activities | -537,000USD | -36,000USD | 2,541,000USD | 581,000USD | 2,000USD | 969,000USD | 2,402,000USD | 1,311,000USD |
| Unclassified Financing Cash Flow | 17,605,000USD | 7,012,000USD | — | — | — | — | — | — |
| Change To Account Receivables | — | — | — | — | — | 0USD | 0USD | 0USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | — | 13,019,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | — | -12,699,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -101,594,000USD | -130,302,000USD | -101,744,000USD | -108,176,000USD | -58,235,000USD | -51,972,000USD | -14,095,000USD |
| Depreciation | 2,281,000USD | 2,499,000USD | 2,415,000USD | 1,608,000USD | 897,000USD | 718,000USD | 643,000USD |
| Stock Based Compensation | 26,430,000USD | 28,897,000USD | 19,079,000USD | 14,230,000USD | 7,833,000USD | 1,764,000USD | 1,694,000USD |
| Other Non Cash Items | 1,196,000USD | -849,000USD | 234,000USD | 1,751,000USD | 1,323,000USD | 890,000USD | -14,741,000USD |
| Change To Account Receivables | 0USD | 0USD | 2,000,000USD | 6,000,000USD | -8,000,000USD | -2,000,000USD | -2,000,000USD |
| Change In Working Capital | -67,199,000USD | -31,746,000USD | -37,966,000USD | -18,493,000USD | -11,345,000USD | 118,674,000USD | 1,696,000USD |
| Total Cash From Operating Activities | -138,886,000USD | -131,501,000USD | -117,982,000USD | -109,080,000USD | -59,527,000USD | 70,074,000USD | -24,803,000USD |
| Capital Expenditures | -1,048,000USD | -754,000USD | -1,526,000USD | -7,692,000USD | -1,837,000USD | -1,106,000USD | -1,817,000USD |
| Free Cash Flow | -139,934,000USD | -132,255,000USD | -119,508,000USD | -116,772,000USD | -61,364,000USD | 68,968,000USD | -26,620,000USD |
| Investments | -39,817,000USD | 86,126,000USD | -5,031,000USD | 34,091,000USD | -181,597,000USD | -144,320,000USD | 2,665,000USD |
| Total Cashflows From Investing Activities | -40,865,000USD | 86,126,000USD | 41,426,000USD | 26,399,000USD | -183,434,000USD | -145,466,000USD | 848,000USD |
| Total Cash From Financing Activities | 222,500,000USD | 47,664,000USD | 82,406,000USD | 1,615,000USD | 357,325,000USD | 80,884,000USD | 11,000,000USD |
| Issuance Of Capital Stock | 212,400,000USD | 41,723,000USD | 80,017,000USD | 0USD | 29,990,000USD | 80,844,000USD | — |
| Change In Cash | 42,749,000USD | 2,289,000USD | 5,850,000USD | -81,066,000USD | 114,364,000USD | 5,492,000USD | 25,168,000USD |
| Begin Period Cash Flow | 72,097,000USD | 69,808,000USD | 63,958,000USD | 145,024,000USD | 30,660,000USD | 25,168,000USD | — |
| End Period Cash Flow | 114,846,000USD | 72,097,000USD | 69,808,000USD | 63,958,000USD | 145,024,000USD | 30,660,000USD | 25,168,000USD |
| Other Cashflows From Financing Activities | -36,000USD | 5,941,000USD | 2,389,000USD | 1,615,000USD | 15,212,000USD | 80,884,000USD | 11,000,000USD |
| Unclassified Financing Cash Flow | 10,136,000USD | — | — | — | -31,048,000USD | -80,844,000USD | — |
| Other Cashflows From Investing Activities | — | 86,126,000USD | — | 34,091,000USD | -181,597,000USD | -40,000USD | 2,665,000USD |
| Unclassified Investing Cash Flow | — | -85,372,000USD | 47,983,000USD | -34,091,000USD | 181,597,000USD | — | -2,665,000USD |
| Change To Inventory | — | — | -6,734,000USD | — | — | 422,000USD | — |
| Change To Liabilities | — | — | — | -8,134,000USD | -10,810,000USD | 120,252,000USD | -15,225,000USD |
| Net Borrowings | — | — | — | 0USD | 342,113,000USD | — | — |
| Cash And Cash Equivalents Changes | — | — | — | -81,066,000USD | 114,364,000USD | — | — |
| Sale Purchase Of Stock | — | — | — | — | 31,048,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2024Yearly · 2024-12-31 | Product | Collaboration Revenue | 29,969,000 | USD | 0001193125-26-092518 |
| FY 2024Yearly · 2024-12-31 | Product | License Revenue | 12,100,000 | USD | 0001193125-26-092518 |
| Q2 2024Quarterly · 2024-06-30 | Product | Collaboration Revenue | 7,775,000 | USD | 0000950170-25-102392 |
| Q2 2024Quarterly · 2024-06-30 | Product | License Revenue | 12,100,000 | USD | 0000950170-25-102392 |
| FY 2023Yearly · 2023-12-31 | Product | Collaboration Revenue | 31,527,000 | USD | 0001193125-26-092518 |
| FY 2023Yearly · 2023-12-31 | Product | License Revenue | 5,000,000 | USD | 0001193125-26-092518 |
| Q2 2023Quarterly · 2023-06-30 | Product | Collaboration Revenue | 9,598,000 | USD | 0000950170-24-092274 |
| Q2 2023Quarterly · 2023-06-30 | Product | License Revenue | 5,000,000 | USD | 0000950170-24-092274 |
| FY 2021Yearly · 2021-12-31 | Product | Collaboration Revenue | 26,042,000 | USD | 0000950170-23-009854 |
| FY 2021Yearly · 2021-12-31 | Product | License Revenue | 11,000,000 | USD | 0000950170-23-009854 |
| Q2 2021Quarterly · 2021-06-30 | Product | Collaboration Revenue | 7,153,000 | USD | 0000950170-22-016257 |
| Q2 2021Quarterly · 2021-06-30 | Product | License Revenue | 11,000,000 | USD | 0000950170-22-016257 |
| FY 2020Yearly · 2020-12-31 | Product | Collaboration Revenue | 6,972,000 | USD | 0000950170-22-004721 |
| FY 2020Yearly · 2020-12-31 | Product | License Revenue | 684,000 | USD | 0000950170-22-004721 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.